Abstract

Human papillomavirus (HPV) is the most common sexually transmitted infection globally, with certain types causing genital warts and others linked to an increased risk of cancer. HPV testing has emerged as a critical tool for managing genital warts and preventing further complications. This article explores the biological underpinnings of HPV, its association with genital warts, and the value of HPV testing in clinical management and public health interventions. By focusing on the prevention and long-term implications of untreated HPV, the discussion underscores the importance of integrating HPV testing into routine healthcare practices.